You are here

  • Home
  • Archive
  • Volume 8, Issue 2
  • Clinicopathological characteristics and management of colitis with anti-PD1 immunotherapy alone or in combination with ipilimumab

Article metrics

Article menu
XML
Clinical/translational cancer immunotherapy
Original research
Clinicopathological characteristics and management of colitis with anti-PD1 immunotherapy alone or in combination with ipilimumab

 

Online download statistics by month:

Online download statistics by month: November 2020 to March 2024

AbstractFullPdf
Nov 202031531595
Dec 2020224224147
Jan 2021737347
Feb 2021656518
Mar 2021747434
Apr 2021565620
May 2021848412
Jun 202110010017
Jul 202110010019
Aug 202111211229
Sep 202110410431
Oct 202110410434
Nov 202113113143
Dec 2021858524
Jan 2022889124
Feb 2022303213
Mar 2022686821
Apr 2022939733
May 2022929215
Jun 20229810130
Jul 2022656726
Aug 2022949423
Sep 2022686816
Oct 2022697222
Nov 2022393918
Dec 202240404
Jan 2023616112
Feb 202362627
Mar 2023757631
Apr 2023484823
May 2023464616
Jun 2023545413
Jul 2023323213
Aug 2023353511
Sep 202337379
Oct 2023323316
Nov 2023585917
Dec 2023454512
Jan 2024293014
Feb 2024484811
Mar 2024919123
Total322432451043